Sound Energy #SOU provides an update on a potential farm-in and operational progress in Morocco Watch Now
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No problem. I don’t disagree with your views on the company. Just observed that a couple of the posters venting have been around for a while...not the usual suspects or the one post ******s. I think the prospects for Avacta are great but appreciate their frustration . That’s all I was trying to get across.
Zoom apologies, the “you” in sorry you got spiked was at the COViD bandwagon investors not you personally. That came across wrong....
I also have a chunk from years ago with BEP at £1.30 due to the consolidation.
No fight intended at all. I just think the placing hatred it overdone as why wouldn’t you take that opportunity if you ran a business, fully agree it sucks if that happens when you bought in at £2+ but as a LTH that will hopefully still be a profit making entry point. Being spiked will be common among COViD stocks for sure.
No offence offended from my posts just trying to put some Substance behind Why I believe in this co short medium and long term
I’m currently sat at a £5k paper loss, frustrated slightly but that’s trading, happy with my investment, yes....... enough said! Go long plenty to come other than COVID which when it comes could be BIG!
could not have put it better myself. Patience people! i am pretty sure Ruane has done his due dilligence with access to a hell of alot more information than us PIs. if he can see the technology works as a value investor he would not take a stake at 120p as opposed to 12p last year
What the **** are you on about? I was in pre-consolidation. Not wanting to pick a fight with you & like the company, but consider the no funding comments followed by the massive placing & daily 2% price decline. I’m in profit but sympathise with those who aren’t.
That’s pretty much it.
A lot (not all) sat on a paper loss jumped in on the COViD bandwagon, simple as. Sorry you got spiked but a good majority of us were here long before Covid and will be here long after. Moaning about your paper loss is fine but listening to the “delays” “no product” “missed the boat” “shafted by the placing” is tiresome and if this comes good ultimately BS, simple as!
As a businessman, being opportunistic is a key trait. We have a great product In Affimers that we’re getting very little attention. Roll up COViD and a chance to showcase them. Share price goes up, Avct capitalise on the spotlight and raise a huge amount at 4% discount ON AIM!!! with a hell of a hedge fund taking a 10m stake. Tell me that’s not great business.
That’s allowed us to progress at the same time projects that would have been shelved and could be revolutionary to the oncology space.
Anyway, rant over - all IMO but give AS a break! He’s just as incentivised with share options tied to share price a profitability.
What more do people want apart from the LFT results that are due any day??
Too many keyboard warriors here Jim “no spark“ said his wife.
Invested but feet on the ground.
Melt brigade. People showing a bit of frustration due to a paper loss. I think they’re entitled to.
Cheers Jim-sparks....nice to have some light hearted banter back on this bb about the melt and shanked brigade alongside some decent debate and knowledge sharing. I feel it’s close and if that 1/3/5 days who cares if it’s life changing for us all and AS and his team.
They’ve put some serious effort into this process!
PMSL Jim, massive crying laughing face emoji. Agree with all btw
Why do I continue to hold avct shares and remain patiently awaiting for the final results:
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents is pleased to announce that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data..."
"These data show that the test strips detect the spike protein in model samples at concentrations within the clinical range found in saliva of patients with COVID-19. Work continues now to refine the test strip design, optimise its performance and get the best detection limit possible in order to generate the highest sensitivity in the final rapid test product.
Following the optimisation of the lateral flow test by Cytiva the design will then be transferred to manufacturing partners in the UK that are currently being put in place by Avacta. The Company is working with these manufacturers to compress the normal manufacturing, clinical validation and regulatory timelines in order to bring a product to market as quickly as possible.
Dr. Alastair Smith, Chief Executive of Avacta Group commented:
“I am delighted with the progress made by our partners at Cytiva and very encouraged by the positive data from the first test devices. We now need to optimise the test performance to achieve the best possible limit of detection as this will ultimately play a significant factor in determining the clinical sensitivity of the test.
This is a really positive step and we aim to have completed the optimisation very soon so that we can begin the transfer to manufacturers. I will be updating the market on progress in due course.”
I have stopped posting here for a while as I believe I am well informed by the official statements by Avacta and to be honest there is little extra information about the technology itself was able to find here, apart from other related information published by some posters. I thank you for it in advance.
I remain confident on our success when it duly arrives, specially on the oncology part of the business.
I will continue visiting the BB now and then to catch with the board.
Good luck all holders whose firm convictions have supported the company in its future. We will definitely help more than just ourselves should avacta platforms become a successful story.
Chengdo - You've automatically assumed I put you in the "Rainbow chasing" camp so apologies for the confusion, I actually think you're just slipping into the impatient PI's camp which I can completely understand.
Rainbow chasers was in reference to the people who piled into COVID stocks in general because they were on the up without any real research on the companies and no intention of holding long term. Absolutely fine to do that but they cant sit and moan about being spiked and the news not coming quick enough for them to make a few quid and scarper.
On the other hand are people who are getting miffed with timelines being mentioned and not "met". Think this is a little bit of naivety from AS in all honesty and semantics is always a dangerous game. A couple or a few to me, might not mean the same to you...it causes confusion, agreed.
Now, lets take a step back from the focus on the RNS dates.
- Yes some good results right now would be great for the value of PI's holdings but remember:
1. Covid isnt going anywhere.
2. This market is huge so even if someone got in there before us (which looks very unlikely) revenues are material
3. AS has a business reputation to uphold. A slip up whilst trying to hurry through work on an unforeseen opportunity could be catastrophic for the reputation of the business.
4. Do we know AS isn't passing on what he is told by Cytiva and then it is actually them causing delays?
5. The business is trying to expand to be able to deal with the sheer potential volume and scale of this market whilst putting a test through a process in months that normally takes years.
6. If there is a delay, maybe AS is working on other pieces of the process simultaneously to offset that.
Nothing here has been done before, there are no blueprints. So IMO I am happy to let timelines slip a little if the outcome is what we are all expecting. As a LTH I would much rather have a business that grows at a pace it can cope with and comes out with its reputation in tact than hold shares in a company that was first to market and last to sell any because it was sub standard. Prime example today!
Anyway, apologies if you were offended at the rainbow chaser comment and that is my 2 cents worth. We all have different risk tolerances, investment horizons and patience levels...hence the difference in opinion.
Interesting post, Cheng. And I worried about Russians trying to nick Avacta affimers top secret formula!
The issue is not "rainbow chasing", the issue is being led to believe early-on how the marvellous characteristics of Affimers would outperform antibodies because they are (allegedly) so much faster and cheaper to produce, as well as offering marvellous specificity, robustness - Oh, and they are already "proven on Zika". Well, we've got antibody tests all the way up the Yin yang but still no sign of Avacta's Affimer test? Perhaps over-promising is the root of the problem rather than rainbow chasing PIs - but that's too much of an inconvenient perspective for some.
Rainbow chasing PI's... why are you here if you arent to make money? Asking for a friend ...
Avct need to back it up from their confidence a few months ago or a few weeks back. If they don't set a high standard its on them for raising people's expectations.
Very very important comment WalshYorkshire......the reputational damage long and short term to the business would be catastrophic if that was to happen. Rainbow chasing / impatient PI's who are annoyed because they haven't made their money yet will soon forget when the news does arrive. The market or wider bimoed industry won't ever forget a failed test
I don't think anybody would argue with you there, WalshYorkshire. But equally, we don't want to get to the stage where it looked as though they never tried.
Whilst I’m as frustrated as the next person at the lack of news, here’s the evidence of rushing something and getting it wrong! I don’t want to hear Avacta ever having failed being spoken about in The Commons.